Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase I MTN-013/IPM 026 safety trial for HIV enters subject screening stage

Nov. 17, 2011

Patient recruitment commences in phase I study of MK-1439 for HIV-1 infection

Nov. 17, 2011

Gilead and Tibotec finalize agreement on single-tablet HIV regimen

Nov. 17, 2011

Novel HIV reverse transcriptase inhibitor prodrugs disclosed

Nov. 8, 2011

Tibotec presents novel HIV integrase inhibitors

Nov. 4, 2011

New HIV integrase inhibitors presented by Critical Outcome Technologies

Nov. 2, 2011

Gilead files NDA for antiretroviral Quad regimen

Oct. 28, 2011

Bristol-Myers Squibb and Gilead Sciences enter licensing agreement for antiretroviral regimen

Oct. 27, 2011

Merck Frosst discloses new HIV reverse transcriptase inhibitors

Oct. 26, 2011

FDA approves label update for Prezista

Oct. 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...